Top Dems Mount Pressure On Becerra To Reverse COVID-19 LDT Policy Stopping FDA Oversight

11 May 2021

Democratic lawmakers are adding to the growing number of voices demanding the US FDA be able to regulate COVID-19 laboratory developed tests. They argue reliable and accurate tests are needed to restart the economy.

U.S. House Energy and Commerce Committee chairman Frank Pallone, D-NJ, speaks during a news conference at the U.S. Capitol on 6 November 2020 — Frank Pallone Jr., D-NJ, is the highest-ranking lawmaker urging the HHS to allow the FDA to oversee COVID-19 LDTs • Source: Alamy

Top US House Democrats have asked the Department of Health and Human Services (HHS) to reverse a Trump administration policy to stop the Food and Drug Administration from reviewing COVID-19 laboratory developed tests (LDTs).

Energy and Commerce Committee chair Frank Pallone Jr., D-NJ, health subcommittee chair Anna Eshoo, D-CA, and oversight and investigations chair...